Atlas Trials

Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®)

Clinical trial NCT03300479 · WITHDRAWN

Trial details

NCT number
NCT03300479
Sponsor
University of Zurich
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Nontraumatic Intracerebral Hemorrhage, Multiple Localized
Start date
2017-06-15
Primary completion
2021-05-14
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.